Who
Corinne Epperly
Director
Company insider
Files Form 4 as: Director, IN8bio; Director, Aveo Pharmaceuticals.
In numbers
- Trades disclosed
- 18
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 2
- Companies where not an officer
- 2
- First trade
- 6 Jan 2021
- Last trade
- 9 May 2026
- Last filed
- 12 May 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 9 May 2026filed 12 May 2026 | INAB IN8biooption or derivative · Biotechnology | SEC FORM 4 Code A | —22,000 at $0.00 | filing |
| 9 May 2026filed 12 May 2026 | INAB IN8biooption or derivative · Biotechnology | SEC FORM 4 Code A | —22,000 at $0.00 | filing |
| 8 May 2025filed 12 May 2025 | INAB IN8biooption or derivative · Biotechnology | SEC FORM 4 Code A | —63,150 at $0.00 | filing |
| 27 Apr 2025filed 7 May 2025 | INAB IN8biooption or derivative · Biotechnology | SEC FORM 4 Code D | —81,967 | filing |
| 27 Apr 2025filed 7 May 2025 | INAB IN8biooption or derivative · Biotechnology | SEC FORM 4 Code A | —81,967 | filing |
| 19 Dec 2024filed 23 Dec 2024 | INAB IN8biooption or derivative · Biotechnology | SEC FORM 4 Code A | —37,655 at $0.00 | filing |
| 12 Jun 2024filed 14 Jun 2024 | INAB IN8biooption or derivative · Biotechnology | SEC FORM 4 Code A | —33,650 at $0.00 | filing |
| 7 Feb 2024filed 8 Feb 2024 | INAB IN8biooption or derivative · Biotechnology | SEC FORM 4 Code A | —12,500 at $0.00 | filing |
| 13 Dec 2023filed 15 Dec 2023 | INAB IN8biooption or derivative · Biotechnology | SEC FORM 4 Code A | —81,967 | filing |
| 13 Dec 2023filed 15 Dec 2023 | INAB IN8biooption or derivative · Biotechnology | SEC FORM 4 Code A | —81,967 | filing |
| 13 Dec 2023filed 15 Dec 2023 | INAB IN8bioBiotechnology | SEC FORM 4 Code A | —81,967 | filing |
| 6 Dec 2023filed 8 Dec 2023 | INAB IN8biooption or derivative · Biotechnology | SEC FORM 4 Code A | —54,800 at $0.00 | filing |
| 19 Jan 2023filed 19 Jan 2023 | Aveo Pharmaceuticalsoption or derivative | SEC FORM 4 Code D | —10,000 | filing |
| 19 Jan 2023filed 19 Jan 2023 | Aveo Pharmaceuticalsoption or derivative | SEC FORM 4 Code D | —15,000 | filing |
| 19 Jan 2023filed 19 Jan 2023 | Aveo Pharmaceuticalsoption or derivative | SEC FORM 4 Code D | —22,500 | filing |
| 7 Jun 2022filed 8 Jun 2022 | Aveo Pharmaceuticalsoption or derivative | SEC FORM 4 Code A | —22,500 at $0.00 | filing |
| 13 Apr 2021filed 14 Apr 2021 | Aveo Pharmaceuticalsoption or derivative | SEC FORM 4 Code A | —15,000 at $0.00 | filing |
| 6 Jan 2021filed 8 Jan 2021 | Aveo Pharmaceuticalsoption or derivative | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.